JPRN-UMIN000038667已完成未知
Efficacy and safety of degludec/liraglutide combination injection switching from basal insulin therapy with the DPP-4 inhibitor in Japanese type 2 diabetic patients - Efficacy and safety of Xultophy combination injection switching from basal insulin therapy with the DPP-4 inhibitor in Japanese type 2 diabetic patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1. Patients with insulin therapy except basal insulin 2. Patients with GLP-1 receptor agonist 3. Patients with severe liver dysfunction 4. Patients with severe infection, operation, trauma 5. Patients with steroid medication 6. Patient with erythropoietin therapy 7. Patients with malignant tumors 8. Patients who have pregnancy or possibilty of pregnancy, or are under lactation 9. Patients who have hypersensitivity to insulin degludec, liraglutide, or teneligliptin 10. Patients who are considered to be not eligible to the study by the doctor
研究者
相似试验
进行中（未招募）
不适用
The efficacy of insulin degludec/liraglutide as add-on therapy in controlling glycaemia in adults with type 2 diabetes inadequately controlled on sulphonylurea with or without metformin therapyDiabetes mellitus, Type 2MedDRA version: 15.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2012-000140-97-DEovo Nordisk A/S429
进行中（未招募）
不适用
The efficacy of insulin degludec/liraglutide as add-on therapy in controlling glycaemia in adults with type 2 diabetes inadequately controlled on sulphonylurea with or without metformin therapyDiabetes mellitus, Type 2MedDRA version: 15.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000140-97-BGovo Nordisk A/S429
进行中（未招募）
不适用
The efficacy of insulin degludec/liraglutide in controlling glycaemia in adults with type 2 diabetes inadequately controlled on GLP-1 receptor agonist and metformin therapyDiabetes Mellitus, Type 2EUCTR2012-000209-63-SKovo Nordisk A/S429
进行中（未招募）
不适用
The efficacy of insulin degludec/liraglutide in controlling glycaemia in adults with type 2 diabetes inadequately controlled on GLP-1 receptor agonist and OAD therapyDiabetes Mellitus, Type 2EUCTR2012-000209-63-HUovo Nordisk A/S429
进行中（未招募）
1 期
Efficacy and safety of liraglutide in combination with metformin compared to metformin alone, in children and adolescents with type 2 diabetes.MedDRA version: 18.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Diabetes Mellitus, Type 2EUCTR2011-002605-29-ATovo Nordisk A/S150